GSA Capital Partners LLP Buys 19,561 Shares of ORTHOFIX MEDICAL INC. (NASDAQ:OFIX)

GSA Capital Partners LLP grew its stake in ORTHOFIX MEDICAL INC. (NASDAQ:OFIX) by 101.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,906 shares of the medical device company’s stock after purchasing an additional 19,561 shares during the quarter. GSA Capital Partners LLP owned approximately 0.10% of ORTHOFIX MEDICAL worth $635,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Invesco Ltd. raised its position in shares of ORTHOFIX MEDICAL by 1.0% in the fourth quarter. Invesco Ltd. now owns 74,977 shares of the medical device company’s stock valued at $1,309,000 after purchasing an additional 767 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in ORTHOFIX MEDICAL by 4.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,348 shares of the medical device company’s stock worth $338,000 after acquiring an additional 836 shares during the period. BNP Paribas Financial Markets increased its position in ORTHOFIX MEDICAL by 5.9% during the fourth quarter. BNP Paribas Financial Markets now owns 36,798 shares of the medical device company’s stock worth $642,000 after acquiring an additional 2,040 shares during the period. Geode Capital Management LLC increased its position in ORTHOFIX MEDICAL by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 841,637 shares of the medical device company’s stock worth $14,699,000 after acquiring an additional 2,448 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in ORTHOFIX MEDICAL by 7.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 36,425 shares of the medical device company’s stock worth $636,000 after acquiring an additional 2,507 shares during the period. 89.76% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on OFIX. JMP Securities reaffirmed a “market perform” rating on shares of ORTHOFIX MEDICAL in a research report on Friday, June 6th. Barrington Research raised shares of ORTHOFIX MEDICAL to a “strong-buy” rating and set a $16.00 price target on the stock in a research report on Monday, June 23rd. Finally, Wall Street Zen lowered shares of ORTHOFIX MEDICAL from a “hold” rating to a “sell” rating in a research report on Friday, June 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, ORTHOFIX MEDICAL currently has an average rating of “Moderate Buy” and an average target price of $21.50.

ORTHOFIX MEDICAL Trading Down 2.4%

Shares of ORTHOFIX MEDICAL stock opened at $10.77 on Monday. The company has a market capitalization of $421.97 million, a price-to-earnings ratio of -2.92 and a beta of 0.82. The company has a quick ratio of 1.50, a current ratio of 2.71 and a debt-to-equity ratio of 0.38. ORTHOFIX MEDICAL INC. has a 12-month low of $10.24 and a 12-month high of $20.73. The firm’s 50-day moving average price is $11.03 and its two-hundred day moving average price is $14.08.

Insiders Place Their Bets

In other ORTHOFIX MEDICAL news, insider Aviva Mcpherron sold 3,728 shares of the stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total transaction of $39,181.28. Following the sale, the insider directly owned 46,322 shares in the company, valued at $486,844.22. This represents a 7.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Massimo Calafiore acquired 10,000 shares of ORTHOFIX MEDICAL stock in a transaction on Friday, May 9th. The shares were purchased at an average price of $12.54 per share, for a total transaction of $125,400.00. Following the completion of the purchase, the chief executive officer directly owned 234,603 shares of the company’s stock, valued at approximately $2,941,921.62. This represents a 4.45% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 113,500 shares of company stock worth $1,394,858 over the last ninety days. Corporate insiders own 1.30% of the company’s stock.

About ORTHOFIX MEDICAL

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.